Congenital Heart Defect News and Research

RSS

A congenital heart defect is a problem with the structure of the heart. It is present at birth. Congenital heart defects are the most common type of major birth defect.

New children's heart valve

New valves and stents made of super-elastic, shape-memory metal alloy combined with less invasive procedure mean quicker recovery for children with heart disease.

16 Feb 2006

Exercise good for children with heart defects

According to a new U.S. study, children born with heart defects who have traditionally been told not to exercise can improve their heart function through programs that involve exertion.

5 Dec 2005

Children with heart defects benefit from exercise

A small but compelling pilot study indicates that many children with serious congenital heart disease, who are typically urged to restrict their activity, can improve their cardiovascular function and exercise capacity through a cardiac rehabilitation program.

5 Dec 2005

World first trial grows blood vessels from patient's own skin

A team of American scientists have successfully implanted blood vessels grown entirely from a patient's own cells.

16 Nov 2005

Researchers test experimental drug Neuprex on infants undergoing heart surgery

UT Southwestern Medical Center is the only institution in the nation approved by the Food and Drug Administration to test an experimental drug on infants undergoing heart surgery to see whether it can help them avoid potentially lethal infections and improve survival.

22 Aug 2005

Researchers discover type of "fuel" that the heart uses can contribute to the severity of heart failures

Researchers have determined how metabolic pathways differ between healthy and failing hearts. Normally, a heart derives its energy from a balance of fatty acids and carbohydrates, specifically glucose.

21 Jul 2005

Quintuplets born to surrogate mother

In what is believed to be a world first, a surrogate mother has given birth to quintuplets.

26 Apr 2005

Infants under one year of age can accept heart transplants from donors of different blood groups

A study showing that infants under one year of age can accept heart transplants from donors of different blood groups without the risk of organ rejection means a better chance of survival for infant patients and more efficient use of donor organs overall.

4 Apr 2005

Treatment of cardiac lesions without anaesthesic

Navarre University Hospital has introduced a novel technique for the treatment of congenital heart defects and involving the percutaneous closure of the patent foramen ovale (PFO) with monitoring through intracavernous ecography.

23 Mar 2005

First evidence of cardiac progenitor cells

The first evidence of cardiac progenitor cells – rare, specialized stem cells located in the newborn heart of rats, mice and humans – has been shown by researchers at the University of California, San Diego (UCSD) School of Medicine. The cells are capable of differentiation into fully mature heart tissue.

10 Feb 2005

Glia cells may be essential for the normal development of nerve cells responsible for hearing and balance

Traditionally viewed as supporting actors, cells known as glia may be essential for the normal development of nerve cells responsible for hearing and balance, according to new University of Utah research. The study is reported in the January 6, 2005 issue of Neuron and is co-authored by scientists at the University of Washington.

6 Jan 2005

Blood vessel plug - amplatzer ductal occluder, performs well in trial

In the largest and longest trial yet of a device called the Amplatzer ductal occluder, a duct that shunts blood flow away from the lungs during fetal development but sometimes fails to close after birth, was successfully closed in almost all patients, according to a new study in the Aug. 4, 2004, issue of the Journal of the American College of Cardiology.

5 Aug 2004

Time bomb in heart leads to heart failure in some congenital heart disease patients

However, surgical correction of certain forms of congenital heart disease may not fix the underlying molecular trigger that drives progressive heart failure and sudden death later in life, according to new research from the University of California, San Diego (UCSD) School of Medicine.

29 Apr 2004

$4.5 million contract to develop heart assist devices for infants

The University of Pittsburgh's McGowan Institute for Regenerative Medicine has been awarded a five-year $4.5 million contract from the National Heart, Lung, and Blood Institute to develop a heart assist device for infants.

28 Apr 2004

Common anemia drug may protect hearts of infants undergoing surgical repair of congenital defects

Medical College of Wisconsin researchers may have promising news for the many infants who are born with a congenital heart defect serious enough to require surgery before their first birthday.

21 Apr 2004